Saturday 17 October 2026
Export QTRX’s income statement to Excel — free account
Quanterix Corporation
QTRX Healthcare Medical Devices
Quanterix Corporation’s revenue for fiscal 2025 (year ended December 2025) was $138.9 million, up 1.07% from fiscal 2024. In the quarter to June 2026, revenue grew 34.4%, EPS fell 35.1% and free cash flow grew 18.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
2.87
0.20
−6.51%
Follow QTRX
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | 4 | 4 | 5 | 4 | 4 | 3 | 5 | 3 | 3 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | (0.11) | 5.21 | 7.16 | 12.17 | 15.10 | 3.18 | 7.33 | 2.44 | (0.87) |
P/S ratio |
0.00 | 6.61 | 10.70 | 10.45 | 15.93 | 13.81 | 4.51 | 8.34 | 2.97 | 1.95 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(9.15) | 0.61 | (5.98) | 1.83 | 3.92 | 10.29 | 5.62 | 5.92 | 5.08 | (1.83) |
P/Operating CF |
(5.78) | (34.39) | (49.67) | (130.74) | 295.64 | (152.54) | (107.41) | (164.84) | (94.80) | (16.49) |
Beneish M-Score |
(2.59) | (2.44) | 1.38 | (1.76) | (2.18) | (2.31) | (2.99) | (2.59) | (2.35) | (0.69) |
P/B ratio |
0.00 | 2.30 | 9.81 | 4.61 | 6.68 | 3.46 | 1.33 | 2.92 | 1.24 | 0.92 |
Price to Tangible BV |
0.00 | 2.30 | 10.77 | 5.65 | 7.56 | 3.63 | 1.36 | 2.97 | 1.25 | 1.97 |
EV/Sales |
0.00 | 3.54 | 9.93 | 8.66 | 14.17 | 10.42 | 1.71 | 6.04 | 1.16 | 1.12 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(0.67) | (3.66) | (13.00) | (18.77) | (52.38) | (24.20) | (3.71) | (39.24) | (4.52) | (2.01) |
EV/FCF |
(0.65) | (3.48) | (12.36) | (13.27) | (44.84) | (18.80) | (2.99) | (32.60) | (4.13) | (1.95) |
Quick Ratio |
3.07 | 4.33 | 2.83 | 6.05 | 4.99 | 11.37 | 11.41 | 8.89 | 7.65 | 1.98 |
Current Ratio |
3.22 | 4.53 | 3.28 | 6.69 | 5.52 | 12.14 | 12.17 | 9.80 | 8.66 | 2.84 |
Net Debt/EBITDA |
0.91 | 2.75 | 1.22 | 2.67 | 6.61 | 7.75 | 3.43 | 8.38 | 6.26 | 1.16 |
Debt/Assets |
27.60% | 10.22% | 11.27% | 4.51% | 2.83% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.76 | 0.14 | 0.19 | 0.06 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.79 | 0.35 | 0.47 | 0.48 | 0.39 | 0.29 | 0.23 | 0.28 | 0.33 | 0.34 |
Operating CF/Net income |
0.64 | 0.71 | 0.91 | 0.64 | 0.74 | 0.86 | 0.49 | 0.66 | 0.91 | 0.72 |
Capex/Depreciation |
(1.18) | (2.35) | (1.11) | (3.00) | (0.74) | (2.54) | (2.15) | (0.50) | (0.52) | (0.11) |
Interest Coverage |
(16.73) | (27.34) | 685.87 | 66.35 | (115.69) | (140.25) | 20.32 | 2.90 | — | — |
| 27.11% | 126.67% | (58.98%) | (48.07%) | (18.84%) | (17.17%) | (24.93%) | (8.01%) | (11.33%) | (34.25%) | |
| (124.22%) | (48.39%) | (39.57%) | (34.35%) | (14.30%) | (14.38%) | (21.30%) | (6.58%) | (9.23%) | (25.97%) | |
ROIC |
0.00% | 0.00% | (462.99%) | (95.71%) | (61.28%) | (79.41%) | (339.54%) | (100.39%) | (80.37%) | (44.21%) |
Return on Tangible Assets |
(108.26%) | (43.67%) | (71.20%) | (32.67%) | (16.28%) | (12.92%) | (26.91%) | (7.85%) | (11.37%) | (66.48%) |
Average Days of Receivables |
81.30 | 89.34 | 65.88 | 70.16 | 72.61 | 78.53 | 65.78 | 75.81 | 85.37 | 78.76 |
Research and Development Expense of Revenue |
96.63% | 71.28% | 42.00% | 28.54% | 23.36% | 25.67% | 25.41% | 21.30% | 22.62% | 25.86% |
Selling, General and Administrative Expense of Revenue |
70.89% | 86.07% | 89.53% | 92.09% | 68.99% | 84.04% | 87.04% | 72.82% | 73.95% | 99.36% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.05 | 0.14 | 0.09 | 0.04 | 0.02 | 0.01 | 0.01 | 0.38 |
Share Based Compensation of Revenue |
5.28% | 9.48% | 12.98% | 11.26% | 11.69% | 14.45% | 14.58% | 13.75% | 14.54% | 14.92% |
Graham Net Nets |
0.82 | 0.42 | 0.08 | 0.15 | 0.11 | 0.25 | 0.64 | 0.30 | 0.70 | 0.33 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(7.27%) | (46.99%) | (7.86%) | (6.94%) | (2.26%) | (3.77%) | (20.30%) | (2.81%) | (9.15%) | (39.62%) |
Free Cash Flow Yield |
(85.00%) | (15.37%) | (7.51%) | (6.25%) | (1.98%) | (4.02%) | (12.66%) | (2.22%) | (9.45%) | (29.44%) |
Revenue per Share |
8.21 | 6.09 | 1.71 | 2.26 | 2.92 | 3.07 | 2.85 | 3.26 | 3.58 | 3.26 |
Operating CF per Share |
(8.28) | (5.88) | (1.31) | (1.04) | (0.79) | (1.32) | (1.31) | (0.50) | (0.92) | (1.81) |
Capex per Share |
(0.25) | (0.30) | (0.07) | (0.43) | (0.13) | (0.38) | (0.31) | (0.10) | (0.09) | (0.06) |
Free Cash Flow per Share |
(8.52) | (6.19) | (1.37) | (1.48) | (0.92) | (1.70) | (1.63) | (0.60) | (1.00) | (1.87) |
Cash per Share |
13.85 | 21.21 | 2.02 | 4.35 | 6.14 | 11.01 | 9.16 | 8.55 | 7.54 | 2.77 |
Shareholders Equity per Share |
6.29 | 17.53 | 1.87 | 5.13 | 6.97 | 12.25 | 9.68 | 9.31 | 8.60 | 6.94 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.29 | 17.53 | 1.87 | 5.13 | 6.97 | 12.25 | 9.68 | 9.31 | 8.60 | 6.94 |
Free Cash Flow |
(18.27) | (23.24) | (30.22) | (37.03) | (27.29) | (61.30) | (60.22) | (22.69) | (38.53) | (79.85) |
Working Capital |
24.29 | 69.54 | 41.37 | 112.83 | 179.80 | 411.98 | 350.18 | 343.11 | 321.59 | 137.50 |
Capital Expenditures |
(0.53) | (1.13) | (1.50) | (10.85) | (3.93) | (13.67) | (11.61) | (3.84) | (3.37) | (2.61) |
Net Current Asset Value |
11.60 | 63.34 | 32.95 | 91.37 | 154.69 | 388.38 | 305.87 | 303.49 | 287.10 | 89.22 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.05 | 0.04 | 0.19 | 0.05 | 0.12 | 0.11 | 0.03 | 0.02 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.36 | 0.26 | 0.46 | 0.30 | 0.38 | 0.30 | 0.27 | 0.43 | 0.38 | 1.00 |
Cash ROIC |
(34.22%) | (15.00%) | (32.46%) | (15.09%) | (6.90%) | (7.32%) | (8.64%) | (3.38%) | (6.22%) | (19.29%) |
Accounts Receivable Turnover |
5.69 | 4.81 | 6.07 | 6.41 | 6.15 | 5.40 | 4.93 | 5.51 | 4.78 | 4.47 |
Accounts Payable Turnover |
5.05 | 4.22 | 4.54 | 5.49 | 6.07 | 5.72 | 9.22 | 10.84 | 9.05 | 7.21 |
Inventory Turnover |
7.78 | 5.05 | 4.14 | 3.64 | 3.02 | 2.47 | 3.07 | 2.23 | 1.84 | 1.69 |
Average Days of Payables |
94.58 | 100.60 | 94.75 | 70.53 | 64.97 | 73.42 | 23.27 | 38.27 | 46.72 | 66.98 |
Days of Inventory on Hand |
56.70 | 101.14 | 110.24 | 127.73 | 141.97 | 176.90 | 102.92 | 198.05 | 220.24 | 270.34 |
Average Receivables |
3.09 | 4.76 | 6.20 | 8.85 | 14.05 | 20.49 | 21.40 | 22.22 | 28.78 | 31.06 |
Average Payables |
1.95 | 3.05 | 4.33 | 5.44 | 6.29 | 8.00 | 6.52 | 4.44 | 6.00 | 10.26 |
Average Inventory |
1.27 | 2.55 | 4.76 | 8.20 | 12.66 | 18.52 | 19.58 | 21.54 | 29.45 | 43.77 |
Average Assets |
22.23 | 64.45 | 79.70 | 118.78 | 220.50 | 386.29 | 467.55 | 431.07 | 417.55 | 412.65 |
Average Common Equity |
(101.87) | (24.62) | 53.47 | 84.86 | 167.39 | 323.54 | 399.44 | 353.95 | 340.00 | 312.88 |
Columns are period end dates